PharmaVentures, April 2008, Pages: 149
system 45
46 Enforcement of intellectualproperty rights as a breach of EC competition law 47
47 Refusal to licenseintellectualproperty rights as an abuse of dominant position 48
48 Patent dispute
Global Industry Analysts, Inc., Feb 2010, Pages: 394
Board (PCB) Layout Tools, Semiconductor IntellectualProperty (SIP), and Services. Annual forecasts are provided for the period 2007 through 2015. Also, a five-year historic analysis is provided
BioInformant, Jan 2010, Pages: 126
of these significant accomplishments at the University of Wisconsin, the Wisconsin Alumni Research Foundation (WARF) filed a series of landmark patents that have affected the intellectualproperty landscape ever since
GBI Research, Aug 2011, Pages: 108
in India 38
5.6.1 Pricing of Pharmaceutical Drugs in India 38
5.6.2 Reimbursements of Pharmaceutical Drugs in India 38
5.7 IntellectualProperty Rights in India 42
5.7.1 Effect of Patent Laws
Global Industry Analysts, Inc., Oct 2010, Pages: 2423
91
Investment Issues and High Costs Delay Rapid Commercialization 91
Guarded and Protective Stance on IntellectualProperty & Open
Knowledge-Sharing
Global Markets Direct, Dec 2010, Pages: 59
with Palau Pharma S.A.
- Avoid IntellectualProperty Rights related issues.
- Explore the dormant and discontinued projects of Palau Pharma S.A and identify potential opportunities in those areas
Global Industry Analysts, Inc., Oct 2010, Pages: 659
Into Collaborations for Pancreatic Cancer Tests 71
Transgenomic LicensesIntellectualProperty from Integragen 71
Health Discovery Inks Agreement with Pancreas, Biliary and
Liver Surgery Center of New York 71
Global Markets Direct, Nov 2011, Pages: 190
., Ltd..
- Avoid IntellectualProperty Rights related issues.
- Explore the dormant and discontinued projects of Kyowa Hakko Kirin Co., Ltd. and identify potential opportunities in those areas.
Keywords
Business Insights, Jan 2010, Pages: 158
to R&D outsourcing strategy, supplier evaluation & selection, contracting, project organization and expectations, supplier management, culture, staff turnover and intellectualproperty.
Key features
Business Insights, June 2009, Pages: 143
of review by institutional review board (IRB) Absence of informed consent Scientific validity Inadequate protection of intellectualproperty Clinical trial logistics Import licenses and applications
Global Industry Analysts, Inc., Oct 2011, Pages: 584
Takes Over Gracel Display 43 Dupont to Enter into an Alliance with Dainippon Screen 44 Merck Enters into Partnership with DELO 44 Merck to Acquire the IntellectualProperty Portfolio of OLED-T 44 CDT
Pharmalicensing Ltd., Dec 2006, Pages: 144
to the deal valuation
6.4.1.1. Intellectualproperty
6.4.1.2. Development phase
6.4.1.3. Cost of clinical trials
6.4.1.4. Risks associated with commercializing too late
6.4.1.5. Benchmark values
6.4.1.6.
Global Markets Direct, Oct 2011, Pages: 101
with Almirall, S.A..
- Avoid IntellectualProperty Rights related issues.
- Explore the dormant and discontinued projects of Almirall, S.A. and identify potential opportunities in those areas.
List
Global Industry Analysts, Inc., Jan 2011, Pages: 354
Kits
6. RECENT INDUSTRY ACTIVITY
Transgenomic LicensesIntellectualProperty from Integragen
Signal Genetics Collaborates with Array BioPharma
Genzyme Divests Genetic Testing Business
Global Markets Direct, Dec 2010, Pages: 67
.
- Exploit collaboration and partnership opportunities with ProStrakan Group plc.
- Avoid IntellectualProperty Rights related issues.
- Explore the dormant and discontinued projects of ProStrakan Group plc
John Wiley and Sons Ltd, Aug 2009, Pages: 618
of Inventor, Innovator, and Entrepreneur.
- Closing Thoughts.
CHAPTER 2. PROTECTING YOUR INVENTION.
- What Is IntellectualProperty?
- How IntellectualProperty Law Works.
- Basic Forms of Intellectual
Espicom Business Intelligence Ltd, Nov 2011
QUARTERLY
MARKET OUTLOOK
Current market size
Unique 5-Year market projections to 2012
Market outlook
Comment & rating, covering 8 key areas such as use of generic drugs, intellectualproperty, pricing